OptiNose (NASDAQ:OPTN – Get Rating) will be releasing its earnings data before the market opens on Thursday, May 11th. Analysts expect OptiNose to post earnings of ($0.16) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. OptiNose (NASDAQ:OPTN – Get Rating) last issued […]
OptiNose, Inc. (NASDAQ:OPTN – Get Rating)’s share price shot up 4.1% on Monday . The company traded as high as $1.83 and last traded at $1.78. 104,715 shares changed hands during trading, a decline of 30% from the average session volume of 150,021 shares. The stock had previously closed at $1.71. OptiNose Trading Up 4.1 […]
Worth Smiling About - Inventors Digest inventorsdigest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inventorsdigest.com Daily Mail and Mail on Sunday newspapers.
Wall Street analysts forecast that OptiNose, Inc. (NASDAQ:OPTN – Get Rating) will announce sales of $17.97 million for the current quarter, Zacks reports. Two analysts have issued estimates for OptiNose’s earnings, with the highest sales estimate coming in at $18.00 million and the lowest estimate coming in at $17.93 million. OptiNose reported sales of $11.96 […]
OptiNose (NASDAQ:OPTN – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or […]